Drug Trial Radar · NCT05733546
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Aug 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
102
Actual
Start
Jan 30, 2023
Primary completion
Sep 2025
Study completion Sep 2025
Sponsor
- Lead sponsor
- COMPASS PathwaysIndustry
- Sponsor type
- Industry
- First posted
- Feb 17, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Safety, Tolerability, pharmacokinetics and efficacy of a single administration of COMP360 in participants with recurrent Major Depressive Disorder.
Conditions
- Major Depressive Disorder
Interventions
PsilocybinDrug
COMP360 Psilocybin administered under supportive conditions
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability of COMP360 PsilocybinTime frame: Up to Week 6
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Kadima Neuropsychiatry Institute
La Jolla, California
Clinical Neuroscience Solutions Inc
Jacksonville, Florida
Sunstone Therapies
Rockville, Maryland
Elixia MA, LLC
Springfield, Massachusetts
Aims Trial
Plano, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.